1-NA-PP1 - CAS 221243-82-9
Not Intended for Therapeutic Use. For research use only.
Category:
Inhibitor
Product Name:
1-NA-PP1
Catalog Number:
221243-82-9
CAS Number:
221243-82-9
COA:
Inquire
MSDS:
Inquire
Targets:
Src
Chemical Structure
CAS 221243-82-9 1-NA-PP1

Related Src Products


CAS 869748-10-7 A-770041

A-770041
(CAS: 869748-10-7)

A-770041 is an selective and orally bioavailable pyrazolo[3,4-d]pyrimidine exhibiting selectivity for Lck compared with previously reported compounds. It is 300...

CAS 476159-98-5 AZM-475271

AZM-475271
(CAS: 476159-98-5)

AZM475271 is orally Src tyrosine kinase inhibitor with potential anticancer and antimetastatic activities. AZM475271 remarkably inhibits growth and metastasis ...

CAS 867331-82-6 TG 100801

TG 100801
(CAS: 867331-82-6)

TG 100801 is the prodrug of TG 100572, which is a multi-targeted kinase inhibitor that inhibit select growth factor receptor tyrosine kinases and Src familt kin...

CGP 77675
(CAS: 234772-64-6)

CGP 77675 selectively inhibited phosphorylation of peptide substrates and autophosphorylation of purified Src (IC50: 5-20 and 40 nM, respectively).

CAS 867334-05-2 TG 100572

TG 100572
(CAS: 867334-05-2)

TG 100572 is a multi-targeted kinase inhibitor that inhibits select growth factor receptor tyrosine kinases and Src familt kinases.

CAS 172889-27-9 PP2

PP2
(CAS: 172889-27-9)

CAS 330161-87-0 SU6656

SU6656
(CAS: 330161-87-0)

SU6656 is a Src family kinase inhibitor developed by the biotechnology company SUGEN Inc (a subsidiary of Pharmacia) in 2000. SU6656 was initially identified as...

CAS 837422-57-8 WH-4-023

WH-4-023
(CAS: 837422-57-8)

WH-4-023 is a potent and selective dual Lck/Src inhibitor with IC50 of 2 nM/6 nM for Lck and Src kinase respectively. The lymphocyte-specific kinase (Lck) is a ...

AP-22161
(CAS: 268741-42-0)

AP-2216, designed to bind selectively to the Src SH2 domain by targeting a cysteine residue, has the potential to be further developed for treating osteoporosis...

CAS 1038395-65-1 KX2-391 dihydrochloride

KX2-391 dihydrochloride
(CAS: 1038395-65-1)

KX2-391 2Hcl is the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell line...

CAS 518058-84-9 KX1-004

KX1-004
(CAS: 518058-84-9)

KX1-004 is an Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect. KX1-004 has been used to protect the...

HG-9-91-01
(CAS: 1456858-58-4)

HG-9-91-01,a small molecule inhibitor that targets specificly salt-inducible kinase (SIKs) IC50: SIK1=0.92 nM; SIK2=6.6 nM; SIK3=9.6 nM

CPDA
(CAS: 1415834-63-7)

CPDA, a 4-substituted 2-pyridin-2-ylamide, has potential to inhibit SHIP2 which was found to enhance insulin signaling through the Akt pathway in viro and great...

CAS 529-53-3 Scutellartln

Scutellartln
(CAS: 529-53-3)

Scutellarein is a flavonoid isolated from Scutellaria lateriflora could improve neuronal injury.

1-Naphthyl PP1 hydrochloride
(CAS: 956025-47-1)

1-Naphthyl PP1 hydrochloride is a selective inhibitor of src family kinases, including v-Src and c-Fyn, tyrosine kinase c-Abl and CAMK II with IC50 values of 1....

AP-22408
(CAS: 268741-43-1)

AP-22408, a Src tyrosine kinase inhibitor, is an orally bioavailable phosphotyrosine mimic resulting from a structurebased design.

WEHI-345 analogue
(CAS: 1354825-62-9)

An analogue of WEHI-345, a pyrazolo-pyridine derivative, is a protein kinase inhibitor and could be significant for studying the mechanism of cancer.

CAS 882663-88-9 AMG-47a

AMG-47a
(CAS: 882663-88-9)

AMG-47a is a potent inhibitor of Lck and T cell proliferation. It has anti-inflammatory activity (ED50 = 11 mg/kg) in the anti-CD3 induced production of IL-2 in...

T338C Src-IN-2
(CAS: 1351927-00-8)

T338C Src-IN-2, a pyrazolopyrimidine detivative, has been found to be a c-Src T338C kinase inhibitor and could be significant for determing the effect of kinase...

CAS 897016-82-9 KX2-391

KX2-391
(CAS: 897016-82-9)

KX2-391 is an orally bioavailable small molecule Src kinase inhibitor with potential antineoplastic activity. Unlike other Src kinase inhibitors which bind to t...